OptimizeRx
OPRX
125 hedge funds and large institutions have $274M invested in OptimizeRx in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 29 increasing their positions, 37 reducing their positions, and 22 closing their positions.
165% more call options, than puts
Call options by funds: $3.27M | Put options by funds: $1.23M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
68% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 22
63% more capital invested
Capital invested by funds: $168M → $274M (+$106M)
14% more funds holding
Funds holding: 110 → 125 (+15)
4.56% more ownership
Funds ownership: 67.35% → 71.91% (+4.6%)
22% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CP
CenterBook Partners
Greenwich,
Connecticut
|
+$4.9M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$3.34M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$3.21M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$3.16M |
| 5 |
GIPM
G2 Investment Partners Management
New York
|
+$2.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.89M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.11M |
| 3 |
RA
Royce & Associates
New York
|
-$1.8M |
| 4 |
D.E. Shaw & Co
New York
|
-$1.46M |
| 5 |
Morgan Stanley
New York
|
-$1.31M |
OPRX Hedge Fund Activity: Q3 2025 in Review
125 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q3 2025, worth a combined $274M — up 63% from $168M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new OPRX positions and 22 closed out — a net gain of 15 holders — while 29 added to existing stakes and 37 trimmed.
The largest buyer was CenterBook Partners, opening a new position worth an estimated $4.9M. The largest seller was Schonfeld Strategic Advisors, cutting an estimated $2.89M.
- 125 institutional investors held OptimizeRx (OPRX) as of Q3 2025, up from 110 in Q2 2025.
- Funds reported $274M of OptimizeRx stock for Q3 2025, up 63% quarter-over-quarter.
- 37 funds opened new OptimizeRx positions in Q3 2025 and 22 closed out, a net change of +15 holders.
- The largest OptimizeRx buyer in Q3 2025 was CenterBook Partners, an estimated $4.9M added.
- The largest OptimizeRx seller in Q3 2025 was Schonfeld Strategic Advisors, an estimated $2.89M sold.
Based on aggregated 13F filings for Q3 2025.